Article (Scientific journals)
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer : a study of the Belgian and Luxembourg Gynaecological Oncology Group
Vergote, Ignace; Van Nieuwenhuysen, Els; De Waele, Stefanie et al.
2022In International Journal of Gynecological Cancer, p. 1-8
Peer Reviewed verified by ORBi
 

Files


Full Text
Belova.pdf
Publisher postprint (605.54 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
BELOVA
Disciplines :
Oncology
Author, co-author :
Vergote, Ignace
Van Nieuwenhuysen, Els
De Waele, Stefanie
Vulsteke, Christof
Lamot, Caroline
Van den Bulck, Heidi
Claes, Nele
Graas, Marie-Pascale
Delbrock, Guy
Spoormans, Isabelle
Vuylsteke, Peter
Honhon, Brigitte
Verhoeven, Didier
De Maeseneer, Daan
Dirix, Luc
Mebis, Jeroen
Vroman, Philippe
Denys, Hannelore
Martinez Mena, Corina
Pelgrims, Gino
Van Steenberghe, Mona
Van Gorp, Toon
GENNIGENS, Christine  ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'oncologie médicale
More authors (13 more) Less
Language :
English
Title :
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer : a study of the Belgian and Luxembourg Gynaecological Oncology Group
Publication date :
2022
Journal title :
International Journal of Gynecological Cancer
ISSN :
1048-891X
eISSN :
1525-1438
Publisher :
Wolters Kluwer Health, Spain
Pages :
1-8
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 09 February 2022

Statistics


Number of views
52 (2 by ULiège)
Number of downloads
1 (1 by ULiège)

Scopus citations®
 
3
Scopus citations®
without self-citations
3
OpenCitations
 
0

Bibliography


Similar publications



Contact ORBi